This market snapshot provides an analysis of the global market for transcatheter aortic heart valve devices. These solutions are used as an alternative to surgical valve devices to repair or replace diseased aortic valve tissue. Devices covered within the scope of this analysis include transcatheter aortic valve repair and replacement devices.
This market snapshot is intended to provide a high-level overview of the global TAVR/TAVI market, with key insights into:
- Unit volumes from 2022 to 2027
- Market forecasts from 2022 to 2027
- Competitive landscape analysis of major competitors
- Insights into key market events for strategics and startups
Companies Mentioned
- Abbott
- Anteris
- Colibri Heart Valve
- Edwards Lifesciences
- Genesis MedTech
- JenaValve Technologies
- Medtronic
- NVT
- ValVention
- Vascular Innovations
